Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by FRANCO DEMONTE and EHAB Y HANNA.
FRANCO DEMONTE
Connection Strength
6.831
EHAB Y HANNA
  1. Transmaxillary exploration of the intracranial portion of the maxillary nerve in malignant perineural disease. Technical note. J Neurosurg. 2007 Sep; 107(3):672-7.
    View in: PubMed
    Score: 0.301
  2. Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clin Cancer Res. 2024 Nov 12.
    View in: PubMed
    Score: 0.248
  3. Skull base surgery for malignant tumors: The 2nd international collaborative study (1995-2015). Head Neck. 2024 Nov; 46(11):2762-2775.
    View in: PubMed
    Score: 0.240
  4. Sinonasal NUT carcinoma: A consecutive case series and systematic review. Head Neck. 2024 01; 46(1):29-36.
    View in: PubMed
    Score: 0.230
  5. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma. Otolaryngol Head Neck Surg. 2023 08; 169(2):435-440.
    View in: PubMed
    Score: 0.220
  6. High-grade transformation of low-grade biphenotypic sinonasal sarcoma: Radiological, morphophenotypic variation and confirmatory molecular analysis. Ann Diagn Pathol. 2022 Apr; 57:151889.
    View in: PubMed
    Score: 0.204
  7. The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center. J Neurosurg. 2022 Jun 01; 136(6):1583-1591.
    View in: PubMed
    Score: 0.200
  8. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope. 2022 02; 132(2):290-297.
    View in: PubMed
    Score: 0.197
  9. Outcomes of orbital exenteration for craniofacial lesions. Cancer. 2021 07 15; 127(14):2465-2475.
    View in: PubMed
    Score: 0.193
  10. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer. 2021 06 01; 127(11):1788-1795.
    View in: PubMed
    Score: 0.191
  11. Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase. J Neurooncol. 2020 Dec; 150(3):367-375.
    View in: PubMed
    Score: 0.182
  12. Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse. Neurosurgery. 2020 01 01; 86(1):E23-E32.
    View in: PubMed
    Score: 0.177
  13. Endoscopic resection of sinonasal malignancies. Head Neck. 2020 04; 42(4):645-652.
    View in: PubMed
    Score: 0.177
  14. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512.
    View in: PubMed
    Score: 0.165
  15. Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown). 2018 06 01; 14(6):611-619.
    View in: PubMed
    Score: 0.159
  16. Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. J Neurosurg. 2019 03 01; 130(3):812-821.
    View in: PubMed
    Score: 0.158
  17. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma. Ann Surg Oncol. 2018 Jun; 25(6):1723-1729.
    View in: PubMed
    Score: 0.157
  18. Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma. Cancer. 2018 02 01; 124(3):514-520.
    View in: PubMed
    Score: 0.152
  19. Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma. J Neurol Surg B Skull Base. 2017 Dec; 78(6):512-518.
    View in: PubMed
    Score: 0.150
  20. Mutation status among patients with sinonasal mucosal melanoma and its impact on survival. Br J Cancer. 2017 Jun 06; 116(12):1564-1571.
    View in: PubMed
    Score: 0.147
  21. Overt and Subclinical Baroreflex Dysfunction After Bilateral Carotid Body Tumor Resection: Pathophysiology, Diagnosis, and Implications for Management. World Neurosurg. 2017 May; 101:559-567.
    View in: PubMed
    Score: 0.145
  22. Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg. 2016 Jan; 124(1):115-21.
    View in: PubMed
    Score: 0.130
  23. Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
    View in: PubMed
    Score: 0.128
  24. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015 Mar; 9(1):51-9.
    View in: PubMed
    Score: 0.120
  25. Endoscopic resection of sinonasal cancers. Curr Oncol Rep. 2014 Feb; 16(2):369.
    View in: PubMed
    Score: 0.117
  26. Esthesioneuroblastoma. Neurosurg Clin N Am. 2013 Jan; 24(1):51-65.
    View in: PubMed
    Score: 0.109
  27. The oncology of otology. Laryngoscope. 2012 Feb; 122(2):393-400.
    View in: PubMed
    Score: 0.102
  28. Feasibility of a robotic surgical approach to reconstruct the skull base. Skull Base. 2011 Mar; 21(2):79-82.
    View in: PubMed
    Score: 0.096
  29. Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011 Jan; 137(1):78-81.
    View in: PubMed
    Score: 0.095
  30. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer. 2010 May 01; 116(9):2215-23.
    View in: PubMed
    Score: 0.091
  31. Malignant tumors of the anterolateral skull base. Neurosurgery. 2010 Jan; 66(1):102-12; discussion 112.
    View in: PubMed
    Score: 0.089
  32. Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results. Arch Otolaryngol Head Neck Surg. 2009 Dec; 135(12):1219-24.
    View in: PubMed
    Score: 0.088
  33. Transantral robotic access to the pituitary gland. Otolaryngol Head Neck Surg. 2009 Sep; 141(3):413-5.
    View in: PubMed
    Score: 0.086
  34. Endodermal sinus tumor of the paranasal sinuses. Head Neck. 2008 Apr; 30(4):539-43.
    View in: PubMed
    Score: 0.078
  35. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31.
    View in: PubMed
    Score: 0.077
  36. Robotic endoscopic surgery of the skull base: a novel surgical approach. Arch Otolaryngol Head Neck Surg. 2007 Dec; 133(12):1209-14.
    View in: PubMed
    Score: 0.077
  37. Prognostic significance of transdural invasion of cranial base malignancies in patients undergoing craniofacial resection. Neurosurgery. 2007 Dec; 61(6):1178-85; discussion 1185.
    View in: PubMed
    Score: 0.077
  38. Impact of Previous Surgery and/or Radiation Therapy on Endoscopic Reconstruction Outcomes. Oper Neurosurg (Hagerstown). 2024 Aug 26.
    View in: PubMed
    Score: 0.061
  39. A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastoma. Head Neck. 2025 Jan; 47(1):81-89.
    View in: PubMed
    Score: 0.061
  40. Induction Chemotherapy for Sinonasal Tumors in Patients Presenting with Brain Invasion and/or Neurological Deficits. J Neurol Surg B Skull Base. 2024 Dec; 85(6):650-658.
    View in: PubMed
    Score: 0.057
  41. Long-term oncological outcomes for endoscopic endonasal versus open surgical approaches for anatomically matched, locally advanced stage T4 sinonasal malignancies with skull base involvement. J Neurosurg. 2024 Mar 01; 140(3):688-695.
    View in: PubMed
    Score: 0.057
  42. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head Neck. 2023 10; 45(10):2525-2532.
    View in: PubMed
    Score: 0.057
  43. Does Time to Initiation of Adjuvant Radiotherapy Affect Reconstruction Outcomes after Endoscopic Resection of Skull Base Malignancies? J Neurol Surg B Skull Base. 2024 Oct; 85(5):445-457.
    View in: PubMed
    Score: 0.057
  44. Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies. Neurosurg Rev. 2023 Jun 29; 46(1):157.
    View in: PubMed
    Score: 0.056
  45. Post-Treatment Imaging Evaluation of the Skull Base. Semin Roentgenol. 2023 07; 58(3):217-236.
    View in: PubMed
    Score: 0.056
  46. Patient, Disease, and Treatment-Related Factors Affecting Progression-Free and Disease-Specific Survival in Recurrent Chondrosarcomas of the Skull Base. Oper Neurosurg (Hagerstown). 2023 01 01; 24(1):33-43.
    View in: PubMed
    Score: 0.054
  47. Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
    View in: PubMed
    Score: 0.053
  48. The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies:a case series. J Neurooncol. 2022 Sep; 159(3):627-635.
    View in: PubMed
    Score: 0.053
  49. Impact of salvage surgery for recurrent sinonasal cancers with skull base and intracranial involvement. J Neurosurg. 2022 Oct 01; 137(4):961-968.
    View in: PubMed
    Score: 0.051
  50. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 05; 131(5):E1468-E1475.
    View in: PubMed
    Score: 0.046
  51. Surgical Management of Skull Base Osteoradionecrosis in the Cancer Population - Treatment Outcomes and Predictors of Recurrence: A Case Series. Oper Neurosurg (Hagerstown). 2020 09 15; 19(4):364-374.
    View in: PubMed
    Score: 0.046
  52. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2021 05 01; 134(5):1392-1398.
    View in: PubMed
    Score: 0.046
  53. A prospective evaluation of health-related quality of life after skull base re-irradiation. Head Neck. 2020 03; 42(3):485-497.
    View in: PubMed
    Score: 0.044
  54. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
    View in: PubMed
    Score: 0.041
  55. Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. J Neurosurg. 2019 07 01; 131(1):184-191.
    View in: PubMed
    Score: 0.040
  56. Endoscopic endonasal resection of sinonasal/anterior skull base malignancy (Kadish C esthesioneuroblastoma). Acta Neurochir (Wien). 2018 Feb; 160(2):361-366.
    View in: PubMed
    Score: 0.038
  57. Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien). 2018 04; 160(4):731-740.
    View in: PubMed
    Score: 0.038
  58. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280.
    View in: PubMed
    Score: 0.038
  59. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):241-247.
    View in: PubMed
    Score: 0.033
  60. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016 04; 38 Suppl 1:E2259-66.
    View in: PubMed
    Score: 0.032
  61. Impact of Chemoradiotherapy on CSF Leak Repair after Skull Base Surgery. J Neurol Surg B Skull Base. 2014 Oct; 75(5):354-7.
    View in: PubMed
    Score: 0.030
  62. Sinonasal adenocarcinoma: a 16-year experience at a single institution. Head Neck. 2014 Oct; 36(10):1490-6.
    View in: PubMed
    Score: 0.029
  63. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014 Apr; 36(4):524-30.
    View in: PubMed
    Score: 0.028
  64. Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck. 2012 Oct; 34(10):1372-6.
    View in: PubMed
    Score: 0.025
  65. Skull base reconstruction: an updated approach. Plast Reconstr Surg. 2011 Sep; 128(3):675-686.
    View in: PubMed
    Score: 0.025
  66. Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol. 2011 Jul 27; 3:32.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.